Skip to main content

Birth dose of hepatitis B vaccine and hepatitis B immune globulin for newborns of hepatitis B surface antigen (HBsAg) positive mothers

CBE ID
0479
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

Percentage of infants born to hepatitis B surface antigen (HBsAg)-positive mothers who receive a birth dose of hepatitis B virus (HBV) vaccine and hepatitis B immune globulin (HBIG)

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.8 Level of Analysis
      1.9 Care Setting
      1.14 Numerator

      Number of infants born to HBsAg positive mothers who receive a birth dose of HBV vaccine and HBIG upon delivery

      1.15 Denominator

      Number of infants born to mothers who tested positive for HBsAg during prenatal screening or upon admission to the hospital for delivery

      Exclusions

      Pregnancies of HBsAg positive mothers which result in any one of the following: stillbirths, voluntary abortions, miscarriages

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Perinatal and Reproductive Health Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      California Department of Public Health
      Steward POC email
                Public Comments